# Treatment of Refractory Gout With ACTH or Methylprednisolone

> **NCT04808856** · NA · UNKNOWN · sponsor: **Shanghai 10th People's Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Gout

## Interventions

- **DRUG:** Adrenocorticotropic Hormone
- **DRUG:** Methylprednisolone Injection

## Key facts

- **NCT ID:** NCT04808856
- **Lead sponsor:** Shanghai 10th People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-04-01
- **Primary completion:** 2022-04-01
- **Final completion:** 2022-04-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2021-03-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04808856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04808856, "Treatment of Refractory Gout With ACTH or Methylprednisolone". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04808856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*